Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 8
2005 5
2006 5
2007 12
2008 7
2009 13
2010 9
2011 9
2012 9
2013 7
2014 11
2015 14
2016 9
2017 8
2018 5
2019 3
2020 1
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 23274955

119 results
Results by year
Filters applied: . Clear all
Page 1
Agalsidase benefits renal histology in young patients with Fabry disease.
Tøndel C, Bostad L, Larsen KK, Hirth A, Vikse BE, Houge G, Svarstad E. Tøndel C, et al. J Am Soc Nephrol. 2013 Jan;24(1):137-48. doi: 10.1681/ASN.2012030316. J Am Soc Nephrol. 2013. PMID: 23274955 Free PMC article.
Long-Term Dose-Dependent Agalsidase Effects on Kidney Histology in Fabry Disease.
Skrunes R, Tøndel C, Leh S, Larsen KK, Houge G, Davidsen ES, Hollak C, van Kuilenburg ABP, Vaz FM, Svarstad E. Skrunes R, et al. Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1470-1479. doi: 10.2215/CJN.01820217. Epub 2017 Jun 16. Clin J Am Soc Nephrol. 2017. PMID: 28625968 Free PMC article.
Reaccumulation of globotriaosylceramide in podocytes after agalsidase dose reduction in young Fabry patients.
Skrunes R, Svarstad E, Kampevold Larsen K, Leh S, Tøndel C. Skrunes R, et al. Nephrol Dial Transplant. 2017 May 1;32(5):807-813. doi: 10.1093/ndt/gfw094. Nephrol Dial Transplant. 2017. PMID: 27190352
Evaluation of a low dose, after a standard therapeutic dose, of agalsidase beta during enzyme replacement therapy in patients with Fabry disease.
Lubanda JC, Anijalg E, Bzdúch V, Thurberg BL, Bénichou B, Tylki-Szymanska A. Lubanda JC, et al. Genet Med. 2009 Apr;11(4):256-64. doi: 10.1097/GIM.0b013e3181981d82. Genet Med. 2009. PMID: 19265719 Free article. Clinical Trial.
Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial.
Ramaswami U, Bichet DG, Clarke LA, Dostalova G, Fainboim A, Fellgiebel A, Forcelini CM, An Haack K, Hopkin RJ, Mauer M, Najafian B, Scott CR, Shankar SP, Thurberg BL, Tøndel C, Tylki-Szymanska A, Bénichou B, Wijburg FA. Ramaswami U, et al. Mol Genet Metab. 2019 May;127(1):86-94. doi: 10.1016/j.ymgme.2019.03.010. Epub 2019 Apr 3. Mol Genet Metab. 2019. PMID: 30987917 Free article. Clinical Trial.
Kidney function and 24-hour proteinuria in patients with Fabry disease during 36 months of agalsidase alfa enzyme replacement therapy: a Brazilian experience.
Thofehrn S, Netto C, Cecchin C, Burin M, Matte U, Brustolin S, Nunes AC, Coelho J, Tsao M, Jardim L, Giugliani R, Barros EJ. Thofehrn S, et al. Ren Fail. 2009;31(9):773-8. doi: 10.3109/08860220903150296. Ren Fail. 2009. PMID: 19925283 Clinical Trial.
Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa.
Schiffmann R, Ries M, Blankenship D, Nicholls K, Mehta A, Clarke JT, Steiner RD, Beck M, Barshop BA, Rhead W, West M, Martin R, Amato D, Nair N, Huertas P. Schiffmann R, et al. Genet Med. 2013 Dec;15(12):983-9. doi: 10.1038/gim.2013.56. Epub 2013 May 16. Genet Med. 2013. PMID: 23680766 Clinical Trial.
Agalsidase alfa: a review of its use in the management of Fabry disease.
Keating GM. Keating GM. BioDrugs. 2012 Oct 1;26(5):335-54. doi: 10.2165/11209690-000000000-00000. BioDrugs. 2012. PMID: 22946754 Review.
Switch from agalsidase beta to agalsidase alfa in the enzyme replacement therapy of patients with Fabry disease in Latin America.
Ripeau D, Amartino H, Cedrolla M, Urtiaga L, Urdaneta B, Cano M, Valdez R, Antongiovanni N, Masllorens F. Ripeau D, et al. Medicina (B Aires). 2017;77(3):173-179. Medicina (B Aires). 2017. PMID: 28643672 Free article. English.
Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease.
Germain DP, Waldek S, Banikazemi M, Bushinsky DA, Charrow J, Desnick RJ, Lee P, Loew T, Vedder AC, Abichandani R, Wilcox WR, Guffon N. Germain DP, et al. J Am Soc Nephrol. 2007 May;18(5):1547-57. doi: 10.1681/ASN.2006080816. Epub 2007 Apr 4. J Am Soc Nephrol. 2007. PMID: 17409312 Free article. Clinical Trial.
119 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback